Charles Theuer - 01 Feb 2023 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role
President and CEO, Director
Signature
/s/ Scott B. Brown (Attorney-in-Fact)
Issuer symbol
N/A
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
4
Filing time
03 Feb 2023, 18:55:27 UTC
Previous filing
19 Jan 2023
Next filing
02 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCON Employee Stock Option (Right to Buy) Award $0 +332,000 $0.000000 332,000 01 Feb 2023 Common Stock 332,000 $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.